BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 21316136)

  • 1. Preventive protocol for tooth extractions in patients treated with zoledronate: a case series.
    Ferlito S; Puzzo S; Liardo C
    J Oral Maxillofac Surg; 2011 Jun; 69(6):e1-4. PubMed ID: 21316136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dental extractions in patient treated with intravenous bisphosphonates and risk of osteonecrosis of jaws: presentation of a preventive protocol and case series.
    Ferlito S; Liardo C; Puzzo S
    Minerva Stomatol; 2010; 59(11-12):593-601. PubMed ID: 21217623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tooth extraction in patients taking intravenous bisphosphonates: a preventive protocol and case series.
    Lodi G; Sardella A; Salis A; Demarosi F; Tarozzi M; Carrassi A
    J Oral Maxillofac Surg; 2010 Jan; 68(1):107-10. PubMed ID: 20006163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dental extractions in patients receiving bisphosphonate therapy.
    Kyrgidis A; Koloutsos G; Vahtsevanos K
    J Oral Maxillofac Surg; 2010 Jul; 68(7):1704-6; author reply 1706. PubMed ID: 20561478
    [No Abstract]   [Full Text] [Related]  

  • 5. Guidelines for treating patients taking bisphosphonates prior to dental extractions.
    Rogers S; Rahman N; Ryan D; Flint S; Healy C; Stassen LF
    J Ir Dent Assoc; 2010; 56(1):40. PubMed ID: 20337145
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical experiences with bisphosphonate-associated osteonecrosis of the jaws: analysis of 21 cases.
    Junquera L; Gallego L; Cuesta P; Pelaz A; de Vicente JC
    Am J Otolaryngol; 2009; 30(6):390-5. PubMed ID: 19880027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bisphosphonate-induced osteonecrosis of the jaws: prospective study of 80 patients with multiple myeloma and other malignancies.
    Boonyapakorn T; Schirmer I; Reichart PA; Sturm I; Massenkeil G
    Oral Oncol; 2008 Sep; 44(9):857-69. PubMed ID: 18282788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Jaw avascular osteonecrosis after treatment of multiple myeloma with zoledronate.
    Lobato JV; Maurício AC; Rodrigues JM; Cavaleiro MV; Cortez PP; Xavier L; Botelho C; Hussain NS; Santos JD
    J Plast Reconstr Aesthet Surg; 2008; 61(1):99-106. PubMed ID: 18068658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tooth extraction in patients on zoledronic acid therapy.
    Mozzati M; Arata V; Gallesio G
    Oral Oncol; 2012 Sep; 48(9):817-21. PubMed ID: 22483860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computerized tomographic findings in bisphosphonate-associated osteonecrosis of the jaw in patients with cancer.
    Bianchi SD; Scoletta M; Cassione FB; Migliaretti G; Mozzati M
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Aug; 104(2):249-58. PubMed ID: 17560140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diphosphonates can cause necrosis of the jaw. Patients with malignant skeletal diseases are at risk].
    Jarnbring F; Ulmner M; Blomlöf J; Ljungman P
    Lakartidningen; 2006 May 31-Jun 6; 103(21-22):1741-3. PubMed ID: 16826719
    [No Abstract]   [Full Text] [Related]  

  • 12. Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment.
    Marx RE; Sawatari Y; Fortin M; Broumand V
    J Oral Maxillofac Surg; 2005 Nov; 63(11):1567-75. PubMed ID: 16243172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Jaw osteonecrosis associated with bisphosphonates: multiple exposed areas and its relationship to teeth extractions. Study of 20 cases.
    Bagan JV; Jimenez Y; Murillo J; Hernandez S; Poveda R; Sanchis JM; Diaz JM; Scully C
    Oral Oncol; 2006 Mar; 42(3):327-9. PubMed ID: 16275156
    [No Abstract]   [Full Text] [Related]  

  • 14. Bisphosphonate-related osteonecrosis of the jaws--report of 2 cases and strategies on prevention and management.
    Wong YK; Cheng JC
    Quintessence Int; 2008 Mar; 39(3):195-201. PubMed ID: 18618033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bisphosphonate treatment: an orthodontic concern calling for a proactive approach.
    Zahrowski JJ
    Am J Orthod Dentofacial Orthop; 2007 Mar; 131(3):311-20. PubMed ID: 17346585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Focus: Drug-related osteonecrosis of the jaw].
    Schmouchkovitch A; Remaud M; Simon H; Herry H; Le Toux G; Boisramé S
    Presse Med; 2018 Jan; 47(1):19-33. PubMed ID: 29275972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bisphosphonate treatment as a cause of jaw osteonecrosis.
    Kanat O; Ozet A; Ataergin S; Kuzhan O; Arpaci F; Ozturk B; Komurcu S; Ozturk M
    Oral Dis; 2007 May; 13(3):346-7. PubMed ID: 17448221
    [No Abstract]   [Full Text] [Related]  

  • 18. Bisphosphonates, osteonecrosis, osteogenesis imperfecta and dental extractions: a case series.
    Schwartz S; Joseph C; Iera D; Vu DD
    J Can Dent Assoc; 2008; 74(6):537-42. PubMed ID: 18644240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bisphosphonate-associated osteonecrosis of the jaws. 3. Two case reports].
    Schortinghuis J; Meijndert L; de Visscher JG; Witjes MJ
    Ned Tijdschr Tandheelkd; 2007 Oct; 114(10):432-5. PubMed ID: 17972612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia.
    Mavrokokki T; Cheng A; Stein B; Goss A
    J Oral Maxillofac Surg; 2007 Mar; 65(3):415-23. PubMed ID: 17307586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.